AK6P1

Across TCGA pan-cancer cohorts, AK6P1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of AK6P1’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where AK6P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types AK6P1 is over-expressed in tumor.

UCEC and COAD are the cancer types where AK6P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in AK6P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	All	+0.228	.015	6	view →
COAD	All	II,III,IV	+0.333	.002	5	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

AK6P1–UCEC

Open the UCEC breakdown →